Sigma Planning Corp’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
Sigma Planning Corp's EDIT Position: Q3 2024 in Review
Sigma Planning Corp sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 12,729 shares — an estimated $59.4K sold.
Sigma Planning Corp first reported a position in EDIT in Q1 2018 and held it in 15 quarters. The position peaked at $452K in Q3 2021. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.
- Sigma Planning Corp reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
- Sigma Planning Corp sold 12,729 Editas Medicine shares in Q3 2024, an estimated $59.4K.
- Sigma Planning Corp first reported a position in Editas Medicine in Q1 2018 and held it in 15 quarters.
- Sigma Planning Corp's Editas Medicine position peaked at $452K in Q3 2021.
- 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.
Based on Sigma Planning Corp's 13F filing for Q3 2024, filed 4 Nov 2024.